spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Bio-engineered R stent 

 HSMN NewsFeed - 24 Sep 2010
Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeich's Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jun 2010
Data Show OrbusNeich's Genous Bio-engineered R stent is Safe and Effective in Combination with Drug-Eluting Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 26 May 2010
Data Presented at EuroPCR 2010 Demonstrate Effectiveness of OrbusNeich's Genous Bio-engineered R stent in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 26 May 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Apr 2010
OrbusNeich Announces Full Availability of Genous(TM) Bio-engineered Cobalt Chromium Stent Following CE Mark Approval
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 Apr 2010
OrbusNeich Granted Patent for 'Stent with Helical Elements' - Patent Infringement Case Against Boston Scientific Expanded
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Feb 2010
OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Dec 2009
Al Novak Elected Chairman of the Board of OrbusNeich Medical
Devices Interventional Personnel
 HSMN NewsFeed - 1 Dec 2009
OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Safe in a Broad Population of Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2009
Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Apr 2009
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2009
OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 28 Jul 2008
OrbusNeich Adds Sapphire(TM) NC Coronary Dilatation Catheter to Product Line-Up
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Jul 2008
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Jun 2008
OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 28 May 2008
OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 May 2008
Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Apr 2008
OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Feb 2008
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jan 2008
OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Nov 2007
5,000 Patients Treated With OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Now Enrolled in Real-Life Use Global Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2007
Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jul 2007
OrbusNeich Expands Global Sales and Marketing Team
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 23 May 2007
Efficacy of OrbusNeich's Genous(TM) Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2007
OrbusNeich Receives CE Mark Approval for Blazer(TM) Cobalt Chromium Stent, Sapphire(TM) PTCA Dilatation Catheter, Lumina(TM) Guiding Catheter
Devices Regulatory Interventional Cardiology
Return to NewsFeed  

 Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 5 additional stories matching:
Bio-engineered R stent
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.